-
The Cost of Managing Postpartum Hemorrhage: An Analysis by a Brazilian Health Insurer
Mar 10, 2025, 14:00 PM -
Exploring the Potential Health Economic Value of the Aldosterone Synthase inhibitor and Sodium Glucose Transporter 2 inhibitor Combination in Chronic Kidney Disease
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Increasing Costs of Hospitalizations for Multiple Myeloma in the United States: A Database Analysis on Aggregate Costs and Patient Subpopulations
Mar 10, 2025, 14:00 PM -
Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary
Mar 10, 2025, 14:00 PM -
Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape
Mar 10, 2025, 14:00 PM -
Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review
Mar 10, 2025, 14:00 PM -
Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis
Mar 10, 2025, 14:00 PM -
Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization Patterns Among Patients With Non-Small Cell Lung Cancer Treated With Amivantamab Monotherapy
Mar 10, 2025, 14:00 PM -
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala
Mar 10, 2025, 14:00 PM -
Updated Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the United States
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM
